Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Michiaki Kojima, Kanami Machida, Sumie Cho, Daichi Watanabe, Hiroyuki Seki, Miyuki Shimoji, Ayuko Imaoka, Hiroshi Yamazaki, F. Peter Guengerich, Katsunori Nakamura, Koujirou Yamamoto, Takeshi Akiyoshi & Hisakazu Ohtani. (2023) The influence of temperature on the metabolic activity of CYP2C9, CYP2C19, and CYP3A4 genetic variants in vitro. Xenobiotica 53:5, pages 357-365.
Read now
Read now
Qiaoli Wang, Xiaotong Han, Jian Li, Xinghui Gao, Yan Wang, Mingzhou Liu, Guicheng Dong & Jiang Yue. (2015) Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine. Xenobiotica 45:4, pages 335-344.
Read now
Read now
Kathleen R. Tucker, David Jacobs, Jacob Manjarrez & Gilbert H. John. (2006) The metabolism of phenobarbital, a drug used for epilepsy, by intestinal flora, Bifidobacterium adolescentis and Bifidobacterium bifidum. Microbial Ecology in Health and Disease 18:1, pages 32-37.
Read now
Read now
Petr Hodek, Lucie Bořek-Dohalská, Bruno Sopko, Miroslav Šulc, Stanislav Smrček, Jiří Hudeček, Josef Janků & Marie Stiborová. (2005) Structural requirements for inhibitors of cytochromes P450 2B: Assessment of the enzyme interaction with diamondoids. Journal of Enzyme Inhibition and Medicinal Chemistry 20:1, pages 25-33.
Read now
Read now
S. Marini, E. Grasso, V. Longo, P. Puccini, B. Riccardi & P. Giovanni Gervasi. (2003) 4-Biphenylaldehyde and 9-anthraldehyde: two fluorescent substrates for determining P450 enzyme activities in rat and human. Xenobiotica 33:1, pages 1-11.
Read now
Read now
David F. V. Lewis. (2002) Molecular modeling of human cytochrome P450–substrate interactions. Drug Metabolism Reviews 34:1-2, pages 55-67.
Read now
Read now
N. Hagen, A. K. Olsen, J. V. Andersen, J. Tjørnelund & S. H. Hansen. (2002) Characterization of mixtures of recombinant human cytochrome P450s as a screening model for metabolic stability in drug discovery. Xenobiotica 32:9, pages 749-759.
Read now
Read now
G. J. Pass & S. McLean. (2002) Inhibition of the microsomal metabolism of 1,8-cineole in the common brushtail possum (Trichosurus vulpecula) by terpenes and other chemicals. Xenobiotica 32:12, pages 1109-1126.
Read now
Read now
D. F. V. Lewis. (2002) Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure. Xenobiotica 32:4, pages 305-323.
Read now
Read now
D. F. V. Lewis, M. G. Bird, M. Dickins, B. G. Lake, P. J. Eddershaw, M. H. Tarbit, P. S. Goldfarb. (2000) Molecular modelling of human CYP2E1 by homology with the CYP102 haemoprotein domain: investigation of the interactions of substrates and inhibitors within the putative active site of the human CYP2E1 isoform. Xenobiotica 30:1, pages 1-25.
Read now
Read now
K. Taguchi, T. Konishi, H. Nishikawa & S. Kitamura. (1999) Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid. Xenobiotica 29:9, pages 899-907.
Read now
Read now
Articles from other publishers (64)
Ling-jing Yuan, Jian-chang Qian, Xiang-yu Li, Ju Cui, Jian-ping Cai & Guo-xin Hu. (2022) Enzymatic activity on valsartan of 38 CYP2C9 variants from the Chinese population. Chemico-Biological Interactions 353, pages 109799.
Crossref
Crossref
Masaki Kumondai, Akio Ito, Evelyn Marie Gutiérrez Rico, Eiji Hishinuma, Akiko Ueda, Sakae Saito, Tomoki Nakayoshi, Akifumi Oda, Shu Tadaka, Kengo Kinoshita, Masamitsu Maekawa, Nariyasu Mano, Noriyasu Hirasawa & Masahiro Hiratsuka. (2021) Functional Assessment of 12 Rare Allelic CYP2C9 Variants Identified in a Population of 4773 Japanese Individuals. Journal of Personalized Medicine 11:2, pages 94.
Crossref
Crossref
Junjun Wang, Ting Zhai & Yong Chen. (2018) Effects of Honokiol on CYP450 Activity and Transporter mRNA Expression in Type 2 Diabetic Rats. International Journal of Molecular Sciences 19:3, pages 815.
Crossref
Crossref
Masaki Kumondai, Hiroki Hosono, Masamitsu Maekawa, Hiroaki Yamaguchi, Nariyasu Mano, Akifumi Oda, Noriyasu Hirasawa & Masahiro Hiratsuka. (2018) Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation. Drug Metabolism and Pharmacokinetics 33:1, pages 82-89.
Crossref
Crossref
Syed Subhani & Kaiser Jamil. (2015) Molecular docking of chemotherapeutic agents to CYP3A4 in non-small cell lung cancer. Biomedicine & Pharmacotherapy 73, pages 65-74.
Crossref
Crossref
M Takahashi, T Saito, M Ito, C Tsukada, Y Katono, H Hosono, M Maekawa, M Shimada, N Mano, A Oda, N Hirasawa & M Hiratsuka. (2014) Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation. The Pharmacogenomics Journal 15:1, pages 26-32.
Crossref
Crossref
Qi Chen & Dongqing Wei. 2015. Advance in Structural Bioinformatics. Advance in Structural Bioinformatics
341
351
.
R T Miller, S Miksys, E Hoffmann & R F Tyndale. (2014)
Ethanol self‐administration and nicotine treatment increase brain levels of
CYP
2
D
in
A
frican green monkeys
. British Journal of Pharmacology 171:12, pages 3077-3088.
Crossref
Crossref
Y Niinuma, T Saito, M Takahashi, C Tsukada, Mi Ito, N Hirasawa & M Hiratsuka. (2013) Functional characterization of 32 CYP2C9 allelic variants. The Pharmacogenomics Journal 14:2, pages 107-114.
Crossref
Crossref
Yuichiro Tamaki, Masashi Honda, Yuka Muroi, Tomio Arai, Haruhiko Sugimura, Yoichi Matsubara, Shuichi Kanno, Masaaki Ishikawa, Noriyasu Hirasawa & Masahiro Hiratsuka. (2011) Novel Single Nucleotide Polymorphism of the CYP2A13 Gene in Japanese Individuals. Drug Metabolism and Pharmacokinetics 26:5, pages 544-547.
Crossref
Crossref
Nicholas A. Warner, Jonathan W. Martin & Charles S. Wong. (2008) Chiral Polychlorinated Biphenyls Are Biotransformed Enantioselectively by Mammalian Cytochrome P-450 Isozymes to Form Hydroxylated Metabolites. Environmental Science & Technology 43:1, pages 114-121.
Crossref
Crossref
Jaya S. Kartha, Konstantine W. Skordos, Hao Sun, Clifton Hall, LaHoma M. Easterwood, Christopher A. Reilly, Eric F. Johnson & Garold S. Yost. (2008) Single Mutations Change CYP2F3 From a Dehydrogenase of 3-Methylindole to an Oxygenase. Biochemistry 47:37, pages 9756-9770.
Crossref
Crossref
Michael Lisurek, Birgit Simgen, Iris Antes & Rita Bernhardt. (2008) Theoretical and Experimental Evaluation of a CYP106A2 Low Homology Model and Production of Mutants with Changed Activity and Selectivity of Hydroxylation. ChemBioChem 9:9, pages 1439-1449.
Crossref
Crossref
Yoshiyuki Hanzawa, Takamitsu Sasaki, Michinao Mizugaki, Masaaki Ishikawa & Masahiro Hiratsuka. (2008)
Genetic Polymorphisms and Haplotype Structures of the Human
CYP2W1
Gene in a Japanese Population
. Drug Metabolism and Disposition 36:2, pages 349-352.
Crossref
Crossref
Praveen Rajendran, Manu Jaggi, Manoj K. Singh, Rama Mukherjee & Anand C. Burman. (2007) Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity. Investigational New Drugs 26:1, pages 25-34.
Crossref
Crossref
Raymond Kemper, Johnnie Hayes & Matthew Bogdanffy. 2007. Principles and Methods of Toxicology, Fifth Edition. Principles and Methods of Toxicology, Fifth Edition
103
178
.
Ge Lin, Jun Tang, Xiao Quan Liu, Yan Jiang & Jiang Zheng. (2007) Deacetylclivorine: A Gender-Selective Metabolite of Clivorine Formed in Female Sprague-Dawley Rat Liver Microsomes. Drug Metabolism and Disposition 35:4, pages 607-613.
Crossref
Crossref
Yoshiyuki Hanzawa, Takamitsu Sasaki, Masahiro Hiratsuka, Masaaki Ishikawa & Michinao Mizugaki. (2007) Three Novel Single Nucleotide Polymorphisme (SNPs) of CYP2S1 Gene in Japanese Individuals. Drug Metabolism and Pharmacokinetics 22:2, pages 136-140.
Crossref
Crossref
P. Crivori & I. Poggesi. (2006) Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs. European Journal of Medicinal Chemistry 41:7, pages 795-808.
Crossref
Crossref
Peter Hlavica. (2006) Functional interaction of nitrogenous organic bases with cytochrome P450: A critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1764:4, pages 645-670.
Crossref
Crossref
Tatsuki Fukami, Miki Nakajima, Eriko Higashi, Hiroyuki Yamanaka, Haruko Sakai, Howard L. McLeod & Tsuyoshi Yokoi. (2005)
CHARACTERIZATION OF NOVEL
CYP2A6
POLYMORPHIC ALLELES (
CYP2A6
*
18
AND
CYP2A6
*
19
) THAT AFFECT ENZYMATIC ACTIVITY
. Drug Metabolism and Disposition 33:8, pages 1202-1210.
Crossref
Crossref
Yoichi Kohno, Shigeyuki Kitamura, Seigo Sanoh, Kazumi Sugihara, Nariaki Fujimoto & Shigeru Ohta. (2005)
METABOLISM OF THE α,β-UNSATURATED KETONES, CHALCONE AND
TRANS
-4-PHENYL-3-BUTEN-2-ONE, BY RAT LIVER MICROSOMES AND ESTROGENIC ACTIVITY OF THE METABOLITES
. Drug Metabolism and Disposition 33:8, pages 1115-1123.
Crossref
Crossref
Aiko Ebisawa, Masahiro Hiratsuka, Kanako Sakuyama, Yumiko Konno, Takamitsu Sasaki & Michinao Mizugaki. (2005) Two Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2D6 Gene in Japanese Individuals. Drug Metabolism and Pharmacokinetics 20:4, pages 294-299.
Crossref
Crossref
Carol A. Kemp, Jean-Didier Maréchal & Michael J. Sutcliffe. (2005) Progress in cytochrome P450 active site modeling. Archives of Biochemistry and Biophysics 433:2, pages 361-368.
Crossref
Crossref
F. Peter Guengerich. 2005. Cytochrome P450. Cytochrome P450
377
530
.
Olena PylypenkoIlme Schlichting. (2004) Structural Aspects of Ligand Binding to and Electron Transfer in Bacterial and Fungal P450s. Annual Review of Biochemistry 73:1, pages 991-1018.
Crossref
Crossref
Christelle Cauffiez, Jean-Marc Lo-Guidice, Sylvie Quaranta, Delphine Allorge, Dany Chevalier, Sylvie Cenée, Rima Hamdan, Michel Lhermitte, Jean-Jacques Lafitte, Christian Libersa, Jean-Frédéric Colombel, Isabelle Stücker & Franck Broly. (2004) Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility. Biochemical and Biophysical Research Communications 317:2, pages 662-669.
Crossref
Crossref
Galina I Lepesheva & Michael R Waterman. (2004) CYP51—the omnipotent P450. Molecular and Cellular Endocrinology 215:1-2, pages 165-170.
Crossref
Crossref
Jun Morita, Kaoru Kobayashi, Atsuko Wanibuchi, Miyuki Kimura, Shin Irie, Takashi Ishizaki & Kan Chiba. (2004) A Novel Single Nucleotide Polymorphism (SNP) of the CYP2C19 Gene in a Japanese Subject with Lowered Capacity of Mephobarbital 4′-Hydroxylation. Drug Metabolism and Pharmacokinetics 19:3, pages 236-238.
Crossref
Crossref
Masahiro Hiratsuka, Yudai Hinai, Yumiko Konno, Hisayoshi Nozawa, Shoetsu Konno & Michinao Mizugaki. (2004) Three Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2B6 Gene in Japanese Individuals. Drug Metabolism and Pharmacokinetics 19:2, pages 155-158.
Crossref
Crossref
Paul F. Hoekstra, Robert J. Letcher, Todd M. O'Hara, Sean M. Backus, Keith R. Solomon & Derek C. G. Muir. (2009)
Hydroxylated and methylsulfone‐containing metabolites of polychlorinated biphenyls in the plasma and blubber of bowhead whales (
Balaena mysticetus
)
. Environmental Toxicology and Chemistry 22:11, pages 2650-2658.
Crossref
Crossref
U. I. Schwarz. (2003)
Clinical relevance of genetic polymorphisms in the human
CYP2C9
gene
. European Journal of Clinical Investigation 33:s2, pages 23-30.
Crossref
Crossref
Mitsuo Miyazawa, Atsushi Sugie & Tsutomu Shimada. (2003) ROLES OF HUMAN CYP2A6 AND 2B6 AND RAT CYP2C11 AND 2B1 IN THE 10-HYDROXYLATION OF (–)-VERBENONE BY LIVER MICROSOMES. Drug Metabolism and Disposition 31:8, pages 1049-1053.
Crossref
Crossref
P. Hlavica, J. Schulze & D.F.V. Lewis. (2003) Functional interaction of cytochrome P450 with its redox partners: a critical assessment and update of the topology of predicted contact regions. Journal of Inorganic Biochemistry 96:2-3, pages 279-297.
Crossref
Crossref
D.F.V. Lewis, B.G. Lake, M. Dickins & P.S. Goldfarb. (2003) Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme–substrate interactions and QSARs for binding affinity and inhibition. Toxicology in Vitro 17:2, pages 179-190.
Crossref
Crossref
David F.V. Lewis,Maurice Dickins,Brian G. Lake,Peter S. Goldfarb,. (2003) A MOLECULAR MODEL OF CYP2D6 CONSTRUCTED BY HOMOLOGY WITH THE CYP2C5 CRYSTALLOGRAPHIC TEMPLATE: INVESTIGATION OF ENZYME-SUBSTRATE INTERACTIONS. Drug Metabolism and Drug Interactions 19:3, pages 189-210.
Crossref
Crossref
David F. V. Lewis. (2003) Quantitative structure–activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s. InflammoPharmacology 11:1, pages 43-73.
Crossref
Crossref
Mark J.I. Paine, Lesley A. McLaughlin, Jack U. Flanagan, Carol A. Kemp, Michael J. Sutcliffe, Gordon C.K. Roberts & C. Roland Wolf. (2003) Residues Glutamate 216 and Aspartate 301 Are Key Determinants of Substrate Specificity and Product Regioselectivity in Cytochrome P450 2D6. Journal of Biological Chemistry 278:6, pages 4021-4027.
Crossref
Crossref
David F.V Lewis. (2003) Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes. Archives of Biochemistry and Biophysics 409:1, pages 32-44.
Crossref
Crossref
D.F.V. Lewis,B.G. Lake,M. Dickins,P.S. Goldfarb,. (2002) Molecular Modelling of CYP2B6 Based on Homology with the CYP2C5 Crystal Structure: Analysis of Enzyme-Substrate Interactions. Drug Metabolism and Drug Interactions 19:2, pages 115-136.
Crossref
Crossref
Tomoko Shiraishi, Masakiyo Hosokawa, Kaoru Kobayashi, Hitoshi Tainaka, Yoshiyuki Yamaura, Miwo Taguchi & Kan Chiba. (2002)
Effects of G169R and P34S Substitutions Produced by Mutations of
CYP2D6*14
on the Functional Properties of CYP2D6 Expressed in V79 Cells
. Drug Metabolism and Disposition 30:11, pages 1201-1205.
Crossref
Crossref
Tashinga E Bapiro, Julia A Hasler, Marianne Ridderström & Collen M Masimirembwa. (2002) The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Biochemical Pharmacology 64:9, pages 1387-1398.
Crossref
Crossref
Stewart B. Kirton, Carol A. Kemp, Nicholas P. Tomkinson, Steven St.‐Gallay & Michael J. Sutcliffe. (2002) Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6. Proteins: Structure, Function, and Bioinformatics 49:2, pages 216-231.
Crossref
Crossref
David F.V. Lewis. (2002) Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template. Journal of Inorganic Biochemistry 91:4, pages 502-514.
Crossref
Crossref
Stewart B Kirton, Carol A Baxter & Michael J Sutcliffe. (2002) Comparative modelling of cytochromes P450. Advanced Drug Delivery Reviews 54:3, pages 385-406.
Crossref
Crossref
D. F. V. Lewis. 2002. Pharmacokinetic Challenges in Drug Discovery. Pharmacokinetic Challenges in Drug Discovery
235
248
.
D.F.V. Lewis,S. Modi,M. Dickins,. (2001) Quantitative Structure-Activity Relationships (QSARs) Within Substrates of Human Cytochromes P450 Involved in Drug Metabolism. Drug Metabolism and Drug Interactions 18:3-4, pages 221-242.
Crossref
Crossref
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
David F.V. Lewis & Peter Hlavica. (2000) Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1460:2-3, pages 353-374.
Crossref
Crossref
David F.V. Lewis. (2000) On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics. Biochemical Pharmacology 60:3, pages 293-306.
Crossref
Crossref
D.F.V. Lewis,. (2000) Modelling Human Cytochromes P450 for Evaluating Drug Metabolism: An Update. Drug Metabolism and Drug Interactions 16:4, pages 307-324.
Crossref
Crossref
Roman A. McLellan, Mikael Oscarson, Mats Hidestrand, Brith Leidvik, Eva Jonsson, Charlotta Otter & Magnus Ingelman-Sundberg. (2000) Characterization and Functional Analysis of Two Common Human Cytochrome P450 1B1 Variants. Archives of Biochemistry and Biophysics 378:1, pages 175-181.
Crossref
Crossref
Robert J. Letcher, Ross J. Norstrom, Derek C.G. Muir, Courtney D. Sandau, Krystyna Koczanski, Robert Michaud, Sylvian De Guise & Pierre Béland. (2009)
Methylsulfone polycglorinated biphenyl and 2,2‐bis(chlorophenyl)‐1,1‐dichloroethylene metabolites in beluga whale (
Delphinapterus leucas
) from the St. Lawrence river estuary and western Hudson bay, Canada
. Environmental Toxicology and Chemistry 19:5, pages 1378-1388.
Crossref
Crossref
David F.V. Lewis. (2000) Structural characteristics of human P450s involved in drug metabolism: QSARs and lipophilicity profiles. Toxicology 144:1-3, pages 197-203.
Crossref
Crossref
Kenji Takanashi, Hitoshi Tainaka, Kaoru Kobayashi, Toshio Yasumori, Masakiyo Hosakawa & Kan Chiba. (2000) CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates. Pharmacogenetics 10:2, pages 95-104.
Crossref
Crossref
Robert J. Letcher, Eva Klasson-Wehler & Ake Bergman. 2000. Volume 3 Anthropogenic Compounds Part K. Volume 3 Anthropogenic Compounds Part K
315
359
.
Georgia J Pass, Stuart McLean & Ieva Stupans. (1999) Induction of xenobiotic metabolising enzymes in the common brushtail possum, Trichosurus vulpecula, by Eucalyptus terpenes. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 124:3, pages 239-246.
Crossref
Crossref
David F.V. Lewis, Brian G. Lake, Stephen G. George, Maurice Dickins, Peter J. Eddershaw, Michael H. Tarbit, Alan P. Beresford, Peter S. Goldfarb & F.Peter Guengerich. (1999) Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Toxicology 139:1-2, pages 53-79.
Crossref
Crossref
Vilia Ann Payne, Yan-Tyng Chang & Gilda H. Loew. (1999) Homology modeling and substrate binding study of human CYP2C18 and CYP2C19 enzymes. Proteins: Structure, Function, and Genetics 37:2, pages 204-217.
Crossref
Crossref
Vilia Ann Payne, Yan-Tyng Chang & Gilda H. Loew. (1999) Homology modeling and substrate binding study of human CYP2C9 enzyme. Proteins: Structure, Function, and Genetics 37:2, pages 176-190.
Crossref
Crossref
Robert J. Letcher, Ineke van Holsteijn, Henk-Jan Drenth, Ross J. Norstrom, Åke Bergman, Stephen Safe, Raymond Pieters & Martin van den Berg. (1999) Cytotoxicity and Aromatase (CYP19) Activity Modulation by Organochlorines in Human Placental JEG-3 and JAR Choriocarcinoma Cells. Toxicology and Applied Pharmacology 160:1, pages 10-20.
Crossref
Crossref
Leposava Antonovič, Petr Hodek, Stanislav Smrček, Petr Novák, Mirek Šulc & Henry W. Strobel. (1999) Heterobifunctional Photoaffinity Probes for Cytochrome P450 2B. Archives of Biochemistry and Biophysics 370:2, pages 208-215.
Crossref
Crossref
David F.V. Lewis. (1999) Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity. Experimental and Toxicologic Pathology 51:4-5, pages 369-374.
Crossref
Crossref
D.F.V Lewis, M Dickins, B.G Lake, P.J Eddershaw, M.H Tarbit & P.S Goldfarb. (1999) Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. Toxicology 133:1, pages 1-33.
Crossref
Crossref